Synthesis and structural characterization of cationic rhenium(V) and technetium(V) dioxo complexes containing four N-heterocyclic carbene ligands

Cationic dioxorhenium and dioxotechnetium complexes of the composition [MO(2)(L(1))(4)](+) (L(1) = 1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene) have been prepared from various starting materials and studied spectroscopically and by X-ray crystallography. The metal-carbon distances range from 2.216(4) to 2.232(4) A indicating mainly sigma-bonding.     

Synthesis and characterization of N-heterocyclic carbene complexes of uranium(III)

Reaction of [(((Ad)ArO)(3)tacn)U(III)] (1) or [((Me(3)Si)(2)N)(3)U(III)] (3) with tetramethylimidazol-2-ylidene (Me(4)IMC:) yields novel N-heterocyclic carbene complexes [(((Ad)ArO)(3)tacn)U(III)(Me(4)IMC:)] (2) and [((Me(3)Si)(2)N)(3)U(III)(Me(4)IMC:)] (4). Uranium complexes 2 and 4 represent the first examples of compounds with an N-heterocyclic carbene ligand coordinated to a low-valent uranium center. The paramagnetic complexes 1, 2, and 4 were characterized by (1)H NMR, UV-vis-NIR, and EPR spectroscopy as well as SQUID magnetization measurements and X-ray diffraction analyses. DFT studies indicate a significant degree of pi-bonding in the U(III)-carbene entity.     

Synthesis and electrochemical properties of novel tetrametallic macrocyclic Fischer carbene complexes

[reaction: see text] Metallomacrocyclic compounds can be easily prepared by 1,4-addition of diamines to alpha,beta-unsaturated Fischer bis-carbene templates. This method allows the preparation of a new family of homo- and heterotetrametallic compounds having macrocyclic cyclophanic structures.     

Stable nitridorhenium(V) complexes with an N-heterocyclic carbene

Nitridorhenium(V) complexes with the nucleophilic cyclocarbene 1,3,4-triphenyl-1,2,4-triazol-5-ylidene have been synthesised and are the first representatives of a new class of high-valent metallocarbenes.     

Platinum (II) N‐heterocyclic carbene complexes: Synthesis,characterization and cytotoxic properties

Platinum (II) complexes bearing N‐heterocyclic carbene (NHC) ligands have been widely used in catalytic chemistry, but there are very few reports of biological properties of this type of complexes. A series of [PtCl₂(NHC)(PEt₃)] complexes were synthesized. The structures of all compounds were characterized by ¹H‐NMR, ¹³C‐NMR, IR and elemental analysis techniques, which supported the proposed structures. The single crystal structures of complexes 1a and 1e were determined. The title complexes show slightly distorted square‐planar coordination around the platinum (II) metal center. The cytotoxic properties of the platinum (II)–NHC complexes have been assessed in various human cancer lines, including cisplatin‐sensitive and resistant cells. IC₅₀ values of these four complexes were determined by the MTS‐based assay on three human cell lines—brain (SHSY5Y), colon (HTC116) and liver (HEP3B). These complexes have been highlighted cancer therapeutic agent with unique structures and functions.     

Synthesis and characterization of vanadium(V)-phosphinimide complexes

Synthetic routes to vanadium(V)-phosphinimide derivatives are addressed. Initial synthetic efforts afforded the known compound formulated as VCl(2)(NPPh(3))(3) which was crystallographically determined to be the salt [VCl(NPPh(3))(3)]Cl (1). Reactions of the vanadium-imide precursors VCl(3)(NAr) (Ar = Ph, C(6)H(3)-2,6-iPr(2)) with R(3)PNSiMe(3) (R = Ph, iPr, tBu) afforded VCl(2)(NPh)(NPPh(3)) (4), VCl(2)(NPh)(NPiPr(3)) (5), VCl(2)(NPh)(NPtBu(3)) (6), VCl(2)(NC(6)H(3)-2,6-iPr(2))(NPPh(3)) (7), VCl(2)(NC(6)H(3)-2,6-iPr(2))(NPiPr(3)) (8), and VCl(2)(NC(6)H(3)-2,6-iPr(2))(NPtBu(3)) (9) in yields ranging from 72% to 84%. Subsequent alkylation or arylation reactions resulted in VMe(2)(NC(6)H(3)-2,6-iPr(2))(NPtBu(3)) (10), VPh(2)(NPh)(NPtBu(3)) (11), VPh(2)(NC(6)H(3)-2,6-iPr(2))(NPiPr(3)) (12), and VPh(2)(NC(6)H(3)-2,6-iPr(2))(NPtBu(3)) (13) while substitution reactions with Li[N(SiMe(3))(2)] and Li[SBn] gave VCl(N(SiMe(3))(2))(NPh)(NPtBu(3)) (14) and V(SBn)(2)(NC(6)H(3)-2,6-iPr(2))(NPtBu(3)) (15) in yields ranging from 40% to 49% yield. Polarization of the N-P phosphinimide bond and V-N multiple bond character are evidenced by crystallographic data.     

Synthesis and characterization of triorganoantimony(V) complexes with bidentate ligands

Monochelated organoantimony(V) complexes of the type R₃Sb(OMe)L, where R = Me or Ph, and L is the anion of acetylacetone, 8-hydroxyquinoline, salicylaldehyde, o-hydroxyacetophenone or 2-hydroxy-1-naphthaldehyde have been obtained from triorganoantimony(V) dibromide and the sodium derivative of the ligands in a benzene-methanol mixture. Molecular weight determination in benzene reveals the monomeric nature of these complexes. IR and NMR data suggest that L acts as a bidentate ligand giving an octahedral environment for the antimony atom.     

Synthesis,characterization and catalytic properties of cationic N-heterocyclic carbene silver complexes

Three new dibenzimidazolium salts bridged by 2-methylenepropane-1,3-diyl group were synthesized. Their dinuclear N-heterocyclic carbene Ag(I) complexes were prepared by the reactions of these salts with Ag₂O. The structures of the synthesized compounds were defined by nuclear magnetic resonance (NMR), Fourier-transform infrared spectroscopy (FT-IR), elemental analysis, and LC-MSMS (for complexes) techniques. Stability of the silver complexes was confirmed by ¹H NMR spectroscopy. Catalytic activities of Ag(I) compounds were tested for three-component coupling reaction of some aldehydes, amines, and phenylacetylene.     

Synthesis and characterization of new cyclopalladated carbene complexes

Di-μ-chlorobis(2-methyl-2-methoxy-3-t-butylthiopropyl)dipalladium(II) reacted with bis(1,3-diphenyl-2-imidazolidinylidene) to afford a new chlorobridged carbene complex [{PdCl(did)}₂] (did  1,3-diphenyl-2-imidazolidinyl-idenato,2-C,2′-C) in 46.2% yield, which has a cyclopalladated chelate structure involving a Pd—carbene and a Pd—aryl bond; new carbene complexes, [{PdBr(did)}₂], [{Pd(CH₃COO)(did)}₂], [Pd(acac)(did)], and [PdCl(did)Q] (Q  4-MePy, P[OCHMe₂]₃) were also prepared from [{PdCl(did)}₂].     

Synthesis and characterization of novel rhenium(I) complexes towards potential biological imaging applications

Background

Re(I) tricarbonyl complexes exhibit immense potential as fluorescence imaging agents. However, only a handful of rhenium complexes have been utilized in biological imaging. The present study describes the synthesis of four novel rhenium complexes, their characterization and preliminary biological studies to assess their potential as biological imaging agents.

Results

Four facial rhenium tricarbonyl complexes containing a pyridyl triazine core, (L1 = 5,5′(3-(2-pyridyl)-1,2,4-triazine-5,6-diyl)-bis-2-furansulfonic acid disodium salt and L2 = (3-(2- pyridyl)-5,6-diphenyl-1,2,4-triazine-4′,4′′-disulfonic acid sodium salt) have been synthesized by utililzing two different Re metal precursors, Re(CO)₅Br and [Re(CO)₃(H₂O)₃]OTf in an organic solvent mixture and water, respectively. The rhenium complexes [Re(CO)₃(H₂O)L1]⁺ (1), Re(CO)₃L1Br (2), [Re(CO)₃(H₂O)L2]⁺ (3), and Re(CO)₃L2Br (4), were obtained in 70–85% yield and characterized by ¹H NMR, IR, UV, and luminescence spectroscopy. In both H₂O and acetonitrile, complexes display a weak absorption band in the visible region which can be assigned to a metal to ligand charge transfer excitation and fluorescent emission lying in the 650–710 nm range. Cytotoxicity assays of complexes 1, 3, and 4 were carried out for rat peritoneal cells. Both plant cells (Allium cepa bulb cells) and rat peritoneal cells were stained using the maximum non-toxic concentration levels of the compounds, 20.00 mg ml^?1 for 1 and 3 and 5.00 mg ml^?1 for 4 to observe under the epifluorescence microscope. In both cell lines, compound concentrated specifically in the nuclei region. Hence, nuclei showed red fluorescence upon excitation at 550 nm.

Conclusions

Four novel rhenium complexes have been synthesized and characterized. Remarkable enhancement of fluorescence upon binding with cells and visible range excitability demonstrates the possibility of using the new complexes in biological applications.

Open image in new window

Graphical abstract Micrograph of rat peritoneal cells incubated with novel rhenium complex under epifluorescence microscope.

     

Synthesis,structural characterization and catalytic potential of oxidovanadium(IV) and dioxidovanadium(V) complexes with thiazole-derived NNN-donor ligand

Reaction between the tridentate NNN donor ligand, (E)-2-(2-(1-(pyridin-2-yl)ethylidene)hydrazinyl)benzo[d]thiazole (HL), and V₂O₅ in ethanol gave a new vanadium(V) complex, [VO₂L] (1), while the similar reaction by using [V^IVO(acac)₂] as the metal source gave two different types of crystals related to compounds [VO₂L] (1) and [V^IVO(acac)L] (2). The molecular structures of the complexes were determined by single-crystal X-ray diffraction and spectroscopic characterization was carried out by means of FT-IR, UV–vis and NMR experiments as well as elemental analysis. The oxidovanadium(IV) and dioxidovanadium(V) species were used as catalyst precursors for olefin oxidation in the presence of hydrogen peroxide (H₂O₂) as an oxidant. Under similar experimental conditions, the presence of 1 resulted in higher oxidation conversion than 2.     

Synthesis, characterization and photoluminescent properties of platinum complexes with novel bis(imidazoline) pincer ligands

Chiral C₂-symmetric bis(imidazoline) pincer ligands 2a-d have been synthesized for the first time. Direct cycloplatination of these ligands with K₂PtCl₄ in dry acetic acid afforded the corresponding cycloplatinated pincer complexes 3a-d. The X-ray single-crystal structure of platinum complex 3d and the preliminary studies on the photoluminescent properties of 3 are reported.     

Synthesis and catalytic properties of N -functionalised carbene complexes of rhodium(I)

Reaction of [RhCl(COD)]₂, with 1,3-dialkylimidazolinylidene (1) or 1,3-dialkylbenzimidazolinylidene (2) resulted in the formation of rhodium(I) 1,3-dialkylimidazolin-2-ylidene (3a-c) and 1,3-dialkylbenzimidazolin-2-ylidene (4a,b) complexes. Triethylsilane reacts with acetophenone derivatives in the presence of catalytic amounts of RhCl(COD)(1,3-dialkylimidazolin-2-ylidene) or RhCl(COD)(1,3-dialkylbenzimidazolin-2-ylidene) to give the corresponding silylethers in good yield (57–98%).     

Synthesis, isolation and characterization of cationic gold(I) N-heterocyclic carbene (NHC) complexes

A number of cationic gold(I) complexes have been synthesized and found to be stabilized by the use of N-heterocyclic carbene ligands. These species are often employed as in situ-generated reactive intermediates in gold catalyzed organic transformations. An isolated, well-defined species was tested in gold-mediated carbene transfer reactions from ethyl diazoacetate.     

Preparation and properties of complexes of chromium(II) with some oxo-anions of phosphorus(V)

Summary Complexes of chromium(II) with diphenylphosphinate, Cr(O₂PPh₂)₂ · H₂O, diphenylphosphate Cr{O₂P(OPh)₂} · 1/2H₂O, phenylphosphinate, Cr(O₂PHPh)₂ · 2H₂O, phenyl-phosphonate, Cr(O₃PPh) · H₂O, and monofluorophosphate, Cr{O₂P(OH)F}₂ · H₂O, are high-spin. From their reflectance spectra and antiferromagnetic behaviour the last three are believed to be three-dimensional polymers with R₂PO ₂ ^– bridges in which some O atoms bridge two Cr atoms, leading to magnetic interaction. The other complexes show only weak magnetic interaction, and the reflectance spectra of Cr(O₂PPh₂)₂ and its hydrate indicate that both contain planar CrO₄ units. It is therefore believed to be a linear polymer with the Cr atoms well separated by double R₂PO ₂ ^– bridges. The reflectance spectrum of Cr{O₂P(OPh)₂}₂ suggests additional weak coordination of O atoms from adjacent polymer chains.     

Synthesis and luminescent properties of cis bis-N-heterocyclic carbene platinum(II) bis-arylacetylide complexes

A series of luminescent N-heterocyclic carbene platinum(II) complexes, [(pmim)Pt(C≡C-R)(2)] (R = C(6)H(5) (2), C(6)H(4)OMe (3), C(6)H(2)(OMe)(3) (4), C(6)H(4)NMe(2) (5), C(4)H(3)S (6), C(6)H(4)C≡CC(6)H(5) (7), 1-pyrenyl (8), and C(6)H(4)F (9)), were successfully synthesized using the precursor (pmim)PtI(2), 1 (pmim = 1,1'-dipentyl-3,3'-methylene-diimidazoline-2,2'-diylidene). The X-ray crystal structures of 1, 4, 5, and 7 have been determined. These complexes showed long-lived emission in solution at room temperature. The emission origin of the complexes is tentatively assigned to be from triplet states of predominantly intraligand (IL) character with some mixing of metal-to-ligand charge-transfer (MLCT) character. TD-DFT and DFT calculations have been performed on most of the complexes to ascertain the nature of the excited state. Changes in the alkynyl ligands lead to a change in the absorption and emission maxima seen for these complexes in a potentially predictable way.     

Synthesis and anticancer properties of gold(I) and silver(I) N-heterocyclic carbene complexes

Bis(1,3-dimethylimidazol-2-ylidene)silver(I) nitrate and bis(4,5-dichloro-1,3-dimethylimidazol-2-ylidene)silver(I) nitrate were prepared by reacting the corresponding imidazolium nitrate salts with silver oxide. Bis(1,3-dimethylimidazol-2-ylidene)gold(I) nitrate and bis(4,5-dichloro-1,3-dimethylimidazol-2-ylidene)gold(I) nitrate salts were prepared via transmetallation of their silver precursors with chloro dimethylsulfide gold. The anticancer properties were determined using NCI-H460 lung cancer cells. Efficacy was established by comparison of the gold and silver compounds with cisplatin.